The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3'-Amino-biphenyl-4-sulfonic acid (2-phenyl-2H-pyrazol-3-yl)-amide ID: ALA333108
PubChem CID: 10916150
Max Phase: Preclinical
Molecular Formula: C21H18N4O2S
Molecular Weight: 390.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1cccc(-c2ccc(S(=O)(=O)Nc3ccnn3-c3ccccc3)cc2)c1
Standard InChI: InChI=1S/C21H18N4O2S/c22-18-6-4-5-17(15-18)16-9-11-20(12-10-16)28(26,27)24-21-13-14-23-25(21)19-7-2-1-3-8-19/h1-15,24H,22H2
Standard InChI Key: HFOVGZDAQJHROY-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
-0.1583 -1.6125 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.0250 -1.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4417 -1.6167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2625 -0.9292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4792 -1.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8542 -0.9792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7583 -1.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1625 -2.2125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1625 -1.0125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9917 -1.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5583 -1.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9500 -0.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9583 -1.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8583 -2.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0583 -1.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0583 -2.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6583 -2.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6583 -1.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4500 -2.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7583 -2.6500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8583 -1.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4583 -1.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2417 0.1083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3500 -0.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7583 -1.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0417 0.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9250 0.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3292 0.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 1 1 0
4 2 1 0
5 2 2 0
6 4 1 0
7 1 1 0
8 1 2 0
9 1 2 0
10 5 1 0
11 13 1 0
12 4 1 0
13 17 1 0
14 11 1 0
15 7 2 0
16 7 1 0
17 16 2 0
18 15 1 0
19 14 2 0
20 19 1 0
21 11 2 0
22 21 1 0
23 12 2 0
24 12 1 0
25 22 2 0
26 24 2 0
27 23 1 0
28 26 1 0
18 13 2 0
10 6 2 0
27 28 2 0
19 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.47Molecular Weight (Monoisotopic): 390.1150AlogP: 3.92#Rotatable Bonds: 5Polar Surface Area: 90.01Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.44CX Basic pKa: 3.86CX LogP: 3.45CX LogD: 2.76Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: -1.66
References 1. Ha-Duong NT, Dijols S, Marques-Soares C, Minoletti C, Dansette PM, Mansuy D.. (2001) Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamily., 44 (22): [PMID:11606127 ] [10.1021/jm010861y ]